InflaRx (NASDAQ:IFRX) 株価情報

InflaRx

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

InflaRx NV

News

Guidance

OR Royalties Updates Long-Term Growth Outlook With Multiple Advancing Projects And Acquires 100% Silver Stream On Orla Mining's South Railroad Project In Nevada; No Financial Terms Disclosed

Invitation Homes Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INVH#NYSE">INVH</a>) ("Invitation Homes" or the "Company") today provided an acquisitions update and announced that it has entered into its first agreement to launch a developer lending program.
During the second quarter to date, the Company partnered with several homebuilders to acquire over 300 newly built single-family homes, representing an investment of more than $100 million. These homes, located in key growth markets including Dallas, Denver, and Nashville, reflect the Company's ongoing commitment to expanding housing supply in high-demand areas.
In addition, the Company announced the launch of its developer lending program with a $32.7 million loan to a homebuilder for purposes of developing a 156-home community in Houston. The loan is secured by the development and its terms include an opportunity for the Company to acquire the community upon stabilization.

INVH

Invitation Homes Invests Over $100M To Acquire 300+ New Homes In Key Growth Markets Located In Dallas, Denver, and Nashville

Streaming giant Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) may have complicated holiday plans for many people in the United States with new "Stranger Things" episodes and <a href="https://www.benzinga.com/general/sports/25/04/44615929/nfl-gets-3-christmas-day-games-in-2025-how-netflix-amazon-will-both-benefit">two NFL games</a> premiering on the platform on Christmas Day.
What Happened: Netflix hosted its Tudum global fan event over the weekend, and many new trailers, release dates and details were shared with fans, including the release dates for the <a href="https://www.benzinga.com/general/entertainment/24/11/41821069/netflix-stock-hits-all-time-highs-company-confirms-stranger-things-season-5-for-2025" target="_blank" rel="noopener">highly anticipated fifth </a>and final season of Stranger Things.
"Stranger Things" will be <a href="https://www.netflix.com/tudum/features/stranger-things-season-5-release-date">released </a>in three parts on the following dates:
<ul class="wp-block-list">
<li>Part 1: four episodes, Nov. 26 (the day before Thanksgiving)</li>
<li>Part 2: three episodes, Dec. 25 (Christmas Day)</li>
<li>Part 3: final episode, Dec. 31</li>
</ul>
All of the episodes will premiere at 5 p.m. PST on the respective dates.
While many people may have their Christmas plans wrapped up on Dec. 25 by the time the new episodes are released, others may look to have parties and celebrations earlier than normal during the day.
Also, keep in mind that Netflix has two Christmas Day NFL games: the Dallas Cowboys vs. the Washington Commanders at 1 p.m. ET and the Detroit Lions vs. the Minnesota Vikings at 4:30 p.m. ET.
This means that Netflix will have premium content for subscribers from 1 p.m. until potentially midnight, depending on the length of the three "Stranger Things" episodes that are released.
The other parts of "Stranger Things" also find release dates around holidays that could complicate family get-togethers and plans.
For comparison, "Stranger Things" season four was released as nine episodes, seven of which were released on May 27 and two on July 1, 2022.
Along with family members upset they might not see as many of their loved ones who want to watch NFL games and "Stranger Things," streaming rival Prime Video might be upset by Netflix's release dates.
The streaming platform, owned by Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), has a third NFL game on Christmas. The Denver Broncos and Kansas City Chiefs will play at 8:15 p.m. ET, right when the new "Stranger Things" episodes will be released.
Read Also:<a href="https://www.benzinga.com/news/entertainment/25/05/45705091/netflix-paramount-dominate-new-top-series-viewers-how-streaming-connection-with-different-age-demographics-helps"> Netflix, Paramount Dominate New Top Series Viewers: How Streaming, Connection With Different Age Demographics Helps</a>
Why It's Important: "Stranger Things" is one of the most-watched series in Netflix history and the final season is among the most anticipated releases on the streaming platforms ever.
Releasing episodes of the hit show around holidays will likely pay off for Netflix in the viewership charts, as people often have time off of work and could binge-watch or catch up on old episodes.
For Netflix, the decision to have two Christmas Day NFL games and "Stranger Things" episodes could be the streamer's decision to plant their flag on the holiday and be the go-to place for homes around the country during the day and at night.
Netflix averaged 24 million viewers for its two Christmas Day 2024 NFL games with 65 million Americans watching at least a portion of one of its two games during the day. The streamer cut into the usual dominance of NBA games that traditionally air on Christmas Day.
"Stranger Things" was not the only highlight from Tudum and also not the only key 2025 release from the streaming giant.
Netflix also <a href="https://www.netflix.com/tudum/features/tudum-2025-the-live-event">highlighted </a>other hits like "Wednesday" season 2 and "Squid Game" season 3, which will be released on Aug. 6 and June 27 respectively. The fan event included a performance by Lady Gaga, who will be featured in the second season of "Wednesday."
The streamer also highlighted upcoming releases like "Frankenstein," "Happy Gilmore 2," "Wake Up Dead Man: A Knives Out Mystery" and season two of "One Piece."
Netflix has new seasons of "Squid Game," "Stranger Things," and "Wednesday" in 2025, giving fans new content for three of its most popular series of all time. Add in NFL games, WWE live matches, and more, and Netflix's 2025 lineup continues to look like one of the best among streamers.
NFLX Price Action: Netflix stock was up 1% to $1,218.98 on Monday, hitting a new 52-week high of $1,219.40 during the trading session. Netflix stock is up 37.5% year-to-date in 2025 and over 90% in the last year.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/entertainment/25/04/44877995/netflix-crushes-q1-says-its-working-hard-to-improve-and-expand-its-offering">Netflix Crushes Q1, Says It&#8217;s &#8216;Working Hard To Improve And Expand&#8217; Its Offering</a></li>
</ul>
Photo: Shutterstock

Entertainment

AMZN

NFLX

Netflix Creates Christmas Day Dilemma: How NFL Games, 'Stranger Things' Season 5 Could Complicate Holidays

At a special meeting of stockholders held on May 30, 2025 (the "Special Meeting") of ClearOne, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>), the Company's stockholders approved a proposal to authorize a reverse stock split of the Company's issued and outstanding common stock, par value $0.001 per share (the "Common Stock") by a ratio of between 1-for-10 and 1-for-15. On May 21, 2025, the Company had previously announced that the Company expected to effect a 1-for-15 reverse stock split with a market effective date of June 3, 2025.
Today the Company announced that the Company will effect a 1-for-15 reverse stock split of the Company's issued and outstanding Common Stock (the "Reverse Stock Split") effective at 5:00 p.m. Eastern time on June 9, 2025 (the "Effective Time"). The Company's Common Stock will begin trading on a reverse stock split adjusted basis on The Nasdaq Capital Market at market open on June 10, 2025.
The Company's Board of Directors has approved the 1-for-15 reverse split ratio and has filed with the Delaware Secretary of State a Certificate of Amendment to its Certificate of Incorporation to effect the Reverse Stock Split at the Effective Time.

Stock Split

CLRO

UPDATE: ClearOne Authorizes 1-For-15 Reverse Stock Split, Will Begin Trading On A Reverse Stock Split Adjusted Basis On The Nasdaq Capital Market At Market Open On June 10, 2025

Centerspace To Acquire Community In Fort Collins, CO, With Closing Expected In Mid-June; Anticipated Purchase Price Is About $132M And Will Include Assumption Of About $76M Of Long-Term, Below-Market Rate Mortgage Debt

VERO

Venus Concept And Subsidiaries Reached Consent Agreement With Madryn Health Partners, Waiving Certain Liquidity Requirements To Apply June 8 Cash Interest Payment To Principal Balance Through June 30, 2025.

Management

BILL

BILL Holdings Names Rohini Jain As CFO, Effective July 7th; John Rettig Will Take On An Expanded Role As Both President And Chief Operating Officer

WIIM

SISI

Shineco shares are trading higher after the company announced that it will raised $13.5 million through the sale of 18 million common shares at $0.75 each to non-US investors.

STIM

Neuronetics Set To Join Russell 3000 Index And Russell 2000 Index, Effective June 30, 2025

<a href="https://www.nytimes.com/2025/06/02/climate/national-petroleum-reserve-alaska-trump-drilling.html" title="https://www.nytimes.com/2025/06/02/climate/national-petroleum-reserve-alaska-trump-drilling.html">https://www.nytimes.com/2025/06/02/climate/national-petroleum-reserve-alaska-trump-drilling.html</a>

Government

Regulations

Legal

'Trump Administration To Open Alaska Wilderness To Drilling And Mining' - New York Times

Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO and former Trump administration adviser Elon Musk is learning a hard truth about Washington, according to investor Ross Gerber. &#8220;After 4 months Elon learned what every natural born American already knows. No one in the government wants to &#8216;cut&#8217; any budget,&#8221; Gerber wrote in a May 24 <a href="https://x.com/GerberKawasaki/status/1926310205442216051">post on X</a>.
Musk has spent the past four months heading up the Department of Government Efficiency, or DOGE, a controversial cost-cutting initiative tied to mass layoffs and agency shutdowns. But even Musk now appears to be frustrated with Washington&#8217;s spending habits. On Thursday, he <a href="https://x.com/elonmusk/status/1927877957852266518">wrote on X</a> that his &#8220;scheduled time&#8221; as a special government employee had come to an end.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">After 4 month Elon learned what every natural born American already knows. No one in the government wants to"cut" any budget. &#x1f602; <a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a>
&mdash; Ross Gerber (@GerberKawasaki) <a href="https://twitter.com/GerberKawasaki/status/1926310205442216051?ref_src=twsrc%5Etfw">May 24, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
</ul>
<h2 class="wp-block-heading">Musk Criticizes Trump&#8217;s Big Spending Bill</h2>
In a recent CBS News <a href="https://www.youtube.com/watch?v=fLbx2PJ4pqE">interview</a>, Musk <a href="https://www.benzinga.com/news/25/05/45635854/elon-musk-disappointed-with-trumps-big-beautiful-bill-says-it-undermines-the-work-that-the-doge-team-is-doing">slammed the Trump administration&#8217;s flagship tax</a> and spending package—dubbed the &#8220;Big, Beautiful Bill&#8221;—saying it &#8220;increases the budget deficit, not just decreases.&#8221; He warned that the legislation &#8220;undermines the work that the DOGE team is doing&#8221; and criticized the government for ignoring the need for real cuts.
The bill, which <a href="https://www.benzinga.com/news/25/05/45581297/trumps-big-beautiful-3-8-trillion-bill-squeaks-through-house-expert-says-it-will-boost-the-economy-in-the-short-term-but-worsen-deficits">passed the House and is now before the Senate</a>, would boost spending on defense and border security, extend tax cuts, and <a href="https://www.benzinga.com/government/regulations/25/05/45506863/trumps-big-beautiful-bill-advances-heres-who-wins-and-loses">slash clean energy</a> and health care programs. Nonpartisan analysts estimate it could add trillions to the national debt.
&#8220;I think a bill can be big or it can be beautiful,&#8221; Musk told CBS. &#8220;But I don&#8217;t know if it can be both.&#8221;
Trending: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
<h2 class="wp-block-heading">From Political Ally To Cautious Critic</h2>
Musk has been a vocal supporter of President Donald Trump and poured over $250 million into his 2024 campaign. But in recent weeks, he&#8217;s pulled back from the political spotlight. During a Tesla <a href="https://seekingalpha.com/article/4777030-tesla-inc-tsla-q1-2025-earnings-call-transcript">earnings call</a>, he said he&#8217;d reduce his time with DOGE starting in May to focus more on the company. &#8220;The large slug of work necessary to get the DOGE team in place&#8230; is mostly done,&#8221; Musk explained.
He added in a CNBC <a href="https://www.cnbc.com/2025/05/20/cnbc-transcript-elon-musk-sits-down-for-secondary-interview-with-cnbcs-david-faber-live-on-cnbc-today-.html">interview</a> that he would now be at the White House just &#8220;a couple days every few weeks.&#8221;
Meanwhile, Tesla is dealing with real-world consequences. European sales of Tesla vehicles <a href="https://www.benzinga.com/markets/eurozone/25/05/45616006/teslas-european-woes-see-no-end-april-sales-crash-49-as-rivals-race-ahead-in-ev-market">fell 49% in April</a>, even as overall electric vehicle sales rose 28%, according to <a href="https://www.acea.auto/files/Press_release_car_registrations_April_2025.pdf">data</a> from the European Automobile Manufacturers&#8217; Association. Analysts blame a mix of factors, including Musk&#8217;s political activity, factory shutdowns, and an aging vehicle lineup.
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
<h2 class="wp-block-heading">Diminishing Impact Of DOGE</h2>
Musk has touted DOGE as a trillion-dollar cost-saving initiative, though watchdogs and fact-checkers have <a href="https://www.benzinga.com/news/25/03/44190325/doge-deletes-billions-in-savings-records-quietly-changing-or-even-erasing-over-1k-contracts-it-claimed-to-have-canceled">questioned its savings claims</a>. So far, the agency <a href="https://doge.gov/savings">claims</a> $175 billion in savings—a figure under dispute.
Musk <a href="https://x.com/elonmusk/status/1925975507759243741">posted</a> last week that while DOGE &#8220;has and will do great work to postpone the day of bankruptcy of America,&#8221; he believes the government's &#8220;profligacy&#8221; means that only radical gains in productivity can truly save the country. He said accelerating GDP growth is now essential, possibly hinting at his push for <a href="https://www.benzinga.com/markets/equities/25/05/45536080/elon-musk-says-teslas-optimus-can-learn-tasks-by-watching-youtube-videos-just-like-a-human">humanoid robots</a> to boost economic output.
Economist Peter Schiff, chief economist and global strategist at Europac.com, dismissed the impact of DOGE, <a href="https://x.com/PeterSchiff/status/1926402967311094105">writing on X</a>: &#8220;Unfortunately I think DOGE was too little, too late to really move the needle on a sovereign debt and dollar crisis. The process has already started.&#8221;
Read Next: How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.
Image: Shutterstock

TSLA

After 4 Months, Elon Musk Learned What Every American Already Knows, Says Ross Gerber: 'No One In Government Wants To Cut Any Budget'

Shopify (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NASDAQ">SHOP</a>) has outperformed the market over the past 10 years by 36.94% on an annualized basis producing an average annual return of 47.96%. Currently, Shopify has a market capitalization of $138.82 billion. 
Buying $1000 In SHOP: If an investor had bought $1000 of SHOP stock 10 years ago, it would be worth $50,250.00 today based on a price of $107.00 for SHOP at the time of writing.
<h3>Shopify's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748896210_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

SHOP

Here's How Much You Would Have Made Owning Shopify Stock In The Last 10 Years

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/AUSAF">Australis Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AUSAF#OTC">AUSAF</a>) shares closed up 29900.00% at $0.0003</li>
<li><a href="https://www.benzinga.com/quote/CNGGF">Cann Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNGGF#OTC">CNGGF</a>) shares closed up 5400.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed up 316.67% at $0.0005</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed up 56.36% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 13.89% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 8.97% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 8.11% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 4.52% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 3.99% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 3.58% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 3.36% at $1.21</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed up 3.05% at $5.40</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed down 52.94% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 50.00% at $0.0001</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 10.10% at $0.89</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 9.76% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 9.48% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 8.00% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 7.66% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 7.58% at $1.21</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed down 7.26% at $1.66</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 6.25% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 5.38% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 4.02% at $0.41</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed down 3.78% at $57.31</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 3.72% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 3.23% at $0.01</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

Movers

AUSAF

BMMJ

CBDY

CNGGF

CNTMF

CVSI

CWBHF

CXXIF

ELLXF

FFNTF

FUAPF

GNLN

GTBIF

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LVRLF

MRMD

OILFF

RMHB

RSSFF

SOLCF

TGIFF

TLRY

YCBD

Cannabis Stock Gainers And Losers From June 2, 2025

On May 29, 2025, Shineco, Inc. (the "Company") entered into a securities purchase agreement (the "SPA") with certain non-U.S. investors (the "Purchasers"), pursuant to which the Company agreed to sell, and the Purchasers agreed to purchase, severally and not jointly, an aggregate of 18,000,000 shares of common stock of the Company (the "Shares") at an offering price of $ 0.75 per share (the "Offering"). Each Purchaser has represented that he or she is not a resident of the United States and is not a "U.S. person" as defined in Rule 902(k) of Regulation S under the Securities Act and is not acquiring the Shares for the account or benefit of any U.S. person. The gross proceeds of the Offering are expected to be approximately $13.5 million, before the deduction of customary expenses.
&nbsp;
In reliance on the Purchasers' representations to the Company, the Shares to be issued in the Offering are not subject to the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), pursuant to Regulation S promulgated thereunder. Neither this Current Report on Form 8-K, nor any exhibit attached hereto, is an offer to sell or the solicitation of an offer to buy the Shares described herein.
&nbsp;
The SPA contains customary representations and warranties of the Company and the Purchasers, indemnification obligations of the Purchasers, and other obligations and rights of the parties. Additionally, the closing of the Offering is conditioned upon the consummation of certain matters by the Company, including, if required by the Nasdaq Listing Rules, submitting a Listing of Additional Shares Notification Form to Nasdaq and obtaining the approval by Nasdaq of the transactions contemplated thereby. Subject to the satisfaction of the closing conditions, the Offering is expected to close on or about June 16, 2025.

Offerings

Shineco To Raise $13.5M Through Sale Of 18M Common Shares At $0.75 Each To Non-U.S. Investors

UBER

Uber Technologies Appoints Andrew "Mac" Macdonald As President & Chief Operating Officer, Effective Immediately

Credo Technology Group Holding Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) reported financial results for the fourth quarter of fiscal 2025 after the market close on Monday. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/06/b45733917/credo-technology-group-holding-ltd-reports-fourth-quarter-and-fiscal-year-2025-financial-results">of the report</a>.
Q4 Earnings: Credo Technology Group reported fourth-quarter revenue of $170.03 million, beating analyst <a href="http://benzinga.com/quote/crdo/earnings">estimates</a> of $162.96 million. The connectivity solutions company reported fourth-quarter adjusted earnings of 35 cents per share, beating analyst estimates of 28 cents per share, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Total revenue in the quarter was up 179.7% year-over-year and up 25.9% sequentially. The company reported adjusted gross margin of 67.4%. Credo Technology Group ended the period with $431.3 million in cash and short-term investments.
&#8220;The Company&#8217;s results were fueled by surging demand for our innovative, reliable and energy-efficient high-performance connectivity solutions. We continue to see growing demand for our solutions across hyperscaler customers to power advanced AI services, a trend we believe will persist for the foreseeable future,&#8221; said Bill Brennan, president and CEO of Credo Technology Group.
Outlook: Credo Technology Group expects first-quarter revenue in the range of $185 million to $195 million versus estimates of $167.83 million. The company anticipates an adjusted gross margin between 64% and 66% in the first quarter.
Credo&#8217;s management team will further discuss the quarter on a conference call with investors and analysts at 5 p.m. ET.
CRDO Price Action: <a href="http://benzinga.com/quote/crdo">Credo Technology shares</a> were up 15.26% in Monday&#8217;s after-hours session, trading at $72.21 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45728618/stocks-stall-commodities-rocket-as-trade-geopolitical-tensions-resume-whats-driving-market-monday">Stocks Stall, Commodities Rocket As Trade, Geopolitical Tensions Resume: What&#8217;s Driving Markets Monday?</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/bluestork">bluestork</a>/Shutterstock.

Earnings

CRDO

Credo Technology Group Q4 Earnings: Revenue Beat, EPS Beat, Strong Guidance, Company Says Results Fueled By 'Surging Demand'

Credo Technology Group Holding shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 sales guidance above estimates.

Strategy&#x2122; (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>, STRK, STRF))) today announced that, subject to market and other conditions, it intends to conduct an initial public offering registered under the Securities Act of 1933, as amended (the "Securities Act"), of 2,500,000 shares of Strategy's 10.00% Series A Perpetual Stride Preferred Stock (the "STRD Stock").
Strategy intends to use the net proceeds from the offering for general corporate purposes, including the acquisition of bitcoin and for working capital.
Dividends on shares of the STRD Stock will not be mandatory. Holders of the STRD Stock will be entitled to receive non-cumulative dividends at a rate per annum equal to 10.00% on the stated amount (as defined below) thereof, out of funds legally available for their payment to the extent paid in cash, only when, as, and if declared by our board of directors or any duly authorized committee thereof. If declared, regular dividends on the STRD Stock will be payable quarterly in arrears on March 31, June 30, September 30 and December 31 of each year, beginning on September 30, 2025. Since regular dividends are not cumulative, Strategy will not have any obligation to pay any regular dividend for any regular dividend period unless Strategy declares such regular dividend prior to the regular dividend payment date for such regular dividend period. No dividend, interest or other amount will accumulate or accrue on any unpaid regular dividends, regardless of whether regular dividends are declared for any future regular dividend period. Declared regular dividends on the STRD Stock will be payable solely in cash in the manner, and subject to the provisions, described in the prospectus supplement for the offering.
Strategy will have the right, at its election, to redeem all, but not less than all, of the STRD Stock, at any time, for cash if the total number of shares of all STRD Stock then outstanding is less than 25% of the total number of shares of STRD Stock originally issued in the offering and in any future offering, taken together. In addition, Strategy will have the right to redeem all, but not less than all, of the STRD Stock if certain tax events occur. The redemption price for any STRD Stock to be redeemed will be a cash amount equal to the liquidation preference of the STRD Stock to be redeemed as of the business day before the date on which Strategy sends the related redemption notice, plus declared and unpaid regular dividends, if any, that will have accrued to, but excluding, the redemption date (and without payment of any undeclared regular dividends).
If an event that constitutes a "fundamental change" under the certificate of designations governing the STRD Stock occurs, then, holders of the STRD Stock will have the right to require Strategy to repurchase some or all of their shares of STRD Stock at a cash repurchase price equal to the stated amount of the STRD Stock to be repurchased, plus declared and unpaid regular dividends, if any, that will have accrued to, but excluding the fundamental change repurchase date (and without payment of any undeclared regular dividends).
The liquidation preference of the STRD Stock will initially be $100 per share (the "stated amount"). Effective immediately after the close of business on each business day after the initial issue date (and, if applicable, during the course of a business day on which any sale transaction to be settled by the issuance of STRD Stock is executed, from the exact time of the first such sale transaction during such business day until the close of business of such business day), the liquidation preference per share will be adjusted to be the greatest of (i) the stated amount per share of STRD Stock; (ii) in the case of any business day with respect to which Strategy has, on such business day or any business day during the ten trading day period preceding such business day, executed any sale transaction to be settled by the issuance of STRD Stock, an amount equal to the last reported sale price per share of STRD Stock on the trading day immediately before such business day; and (iii) the arithmetic average of the last reported sale prices per share of STRD Stock for each trading day of the ten consecutive trading days (or, if applicable, the lesser number of trading days as have elapsed during the period from, and including, the initial issue date to, but excluding, such business day) immediately preceding such business day.

IPOs

MSTR

Strategy Announces Plans For IPO Of 2.5M Shares Of 10% Series A Perpetual Stride Preferred Stock (STRD) To Fund Bitcoin Acquisitions And Corporate Operations

<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1870404/000121390025050055/ea0244195-8k_cero.htm" title="https://www.sec.gov/ix?doc=/Archives/edgar/data/1870404/000121390025050055/ea0244195-8k_cero.htm">https://www.sec.gov/ix?doc=/Archives/edgar/data/1870404/000121390025050055/ea0244195-8k_cero.htm</a>

CERO

CERo Therapeutics Appoints Chris Ehrlich As CEO

At the annual meeting of stockholders of Amaze Holdings, Inc., a Nevada corporation (the "Company"), to be held on June 12, 2025 (the "Annual Meeting"), the Company's stockholders will vote to approve, among other things, a proposal to authorize a reverse stock split of the Company's issued and outstanding common stock, par value $0.001 per share (the "Common Stock"), at a ratio in the range of 1-for-10 and 1-for-50, with such ratio and implementation and timing of the reverse stock split to be determined in the discretion of the Company's Board of Directors (the "Reverse Stock Split Proposal").
&nbsp;
On June 2, 2025, the Company's Board of Directors determined to effect a 1-for-23 reverse stock split of the Company's issued and outstanding Common Stock effective at 5:00 p.m. Eastern time on June 12, 2025 (the "Effective Time"), subject to stockholder approval of the Reverse Stock Split Proposal at the Annual Meeting.
&nbsp;
Upon stockholder approval of the Reverse Stock Split Proposal at the Annual Meeting, immediately following the conclusion of the Annual Meeting on June 12, 2025, the Company will file a certificate of amendment to its Articles of Incorporation to effect the 1-for-23 reverse stock split at the Effective Time. The Company's Common Stock is expected to begin trading on a reverse stock split adjusted basis on the NYSE American at market open on June 13, 2025.
&nbsp;
The reverse stock split is primarily intended to increase the Company's per share market price of its Common Stock to meet the $3.00 per share minimum bid price requirement of the NYSE American Company Guide. The Company's Common Stock will continue to trade on the NYSE American under the trading symbol "AMZE," but will trade under the following new CUSIP number: 35804X 200.

AMZE

Amaze Holdings To Implement 1-For-23 Reverse Stock Split, Aiming To Regain NYSE American Compliance; Stock To Begin Trading On Split-Adjusted Basis June 13, 2025

Press Releases

Infinitum: Pioneering Quantum-Proof Blockchain Solutions to Transform Finance

Financing

InflaRx Announces Closing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

InflaRx to Report Full Year 2024 Results on March 20 and Announces Participation in March Investor Conferences

Health Care

General

InflaRx to Showcase Vilobelimab's Role in Immuno-Dermatology at the 2025 AAD Annual Meeting

InflaRx Showcases Vilobelimab's Role in Immuno-Dermatology at the 2025 AAD Annual Meeting

InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones

InflaRx to Report First Quarter 2025 Results on May 7, 2025

InflaRx Reports First Quarter 2025 Financial Results and Provides Business Update

InflaRx to Participate in Upcoming Investor Conferences

InflaRx Announces Outcome of Interim Analysis for Vilobelimab Phase 3 Trial in Pyoderma Gangrenosum

Comments

InflaRx

ニュース

パートナーシップ

ベンジンガ・グローバル